Ep. 216 - Anti-China Biotech Policy: Biosecure & Beyond

BioCentury This Week

English - February 16, 2024 01:00 - 26 minutes - 18.3 MB - ★★★★★ - 11 ratings
Science biotech biopharma pharmaceutical research investment dealmaking Homepage Download Apple Podcasts Google Podcasts Overcast Castro Pocket Casts RSS feed

Previous Episode: Ep. 215 - ADCs, Psychedelics & IPOs

Next Episode: Ep. 217 - Safer CAR Ts & World’s First TIL Therapy

Anti-China biotech bills are raising alarms at U.S. biotechs, with CEOs worried they could lose access to CDMOs WuXi AppTec and WuXi Biologics, and that legislation could imperil collaboration with Chinese companies more broadly. BIO has warned Congress the bills “would immediately and negatively” affect the U.S. biotech ecosystem. On this special edition of the BioCentury This Week podcast BioCentury Washington Editor Steve Usdin and colleagues discuss the pending legislation.